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Reproductive health concerns raised in our
earlier studies of genotoxicity in pesticide
applicators led us to speculate that the
genomic instability we observed in exposed
workers and expressed as increased chromo-
some rearrangements in G-banded lympho-
cytes and/or molecular rearrangements of
the human T-cell V(d)J region might also
result in developmental and other reproduc-
tive toxicity including birth defects (1,2). As
a ﬁrst effort, we examined the frequencies of
birth defects by crop-growing region in
Minnesota (3) during 1989–1991. The Red
River Valley (RRV) region (northwestern
Minnesota, USA) showed the highest age-
adjusted rate of birth defects compared with
urban areas of Minnesota (26.9 vs.
18.5/1,000 live births). The RRV is a major
wheat, sugar beet, and potato crop–growing
region of our state. At times, these crops
require extensive use of fungicides and rou-
tinely require large amounts of chlorophe-
noxy herbicides. Herbicides are applied in
the spring, insecticides in the summer, and
fungicides as needed in the summer and fall.
Fumigants are routinely applied to stored
harvested grain in the fall. Pesticide applica-
tors from the RRV region demonstrated
even higher age-adjusted levels of birth
defects (30.0/1,000 live births) than did the
general population from the region. The
ratio of male to female children with birth
defects was signiﬁcantly increased in families
of pesticide applicators from the RRV. The
method of birth defect ascertainment
employed in the initial study was birth
records provided to the Minnesota
Department of Health by local health care
providers at the time of birth. Because of the
limited reporting time frame (birth to hospital
discharge of the newborn), the initial study
results were subject to substantial underascer-
tainment. The present cross-sectional study
was undertaken to provide more detailed
information regarding the reproductive health
of pesticide applicators and their families.
Materials and Methods
Overview
Population and population access. In
Minnesota, licensing for application of pesti-
cides commercially or for application to one’s
own farmland requires periodic recertifica-
tion by completion of a program of educa-
tion and examination. Applicators are
licensed to apply speciﬁc classes of pesticides
(herbicides, insecticides, fungicides, and/or
fumigants). Through the Minnesota
Department of Agriculture and the
Minnesota Extension Service, we were pro-
vided with an updated list of licensees cover-
ing the time frame from 1991 through 1996.
Survey strategy. In the ﬁve-county RRV
study area, 3,000 residents were licensed
during the time frame cited. Fifteen hundred
persons were randomly selected for our
umbrella study of general health and pesti-
cide use. The location of 1,340 licensees was
confirmed through telephone and postcard
follow-up. One thousand seventy (1,070)
applicators (98% male) volunteered to par-
ticipate by phone interview for the general
health and pesticide use study. Of this
group, 851 were married or had a marriage-
like relationship. Eight hundred two part-
ners (women) participated in the general
health and pesticide use survey. Each partner
was interviewed by phone at a time separate
from interview of the applicator.
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Endocrine Disruptors
We previously demonstrated that the frequency of birth defects among children of residents of
the Red River Valley (RRV), Minnesota, USA, was signiﬁcantly higher than in other major agri-
cultural regions of the state during the years 1989–1991, with children born to male pesticide
applicators having the highest risk. The present, smaller cross-sectional study of 695 families and
1,532 children, conducted during 1997–1998, provides a more detailed examination of reproduc-
tive health outcomes in farm families ascertained from parent-reported birth defects. In the pre-
sent study, in the ﬁrst year of life, the birth defect rate was 31.3 births per 1,000, with 83% of the
total reported birth defects confirmed by medical records. Inclusion of children identified with
birth or developmental disorders within the ﬁrst 3 years of life and later led to a rate of 47.0 per
1,000 (72 children from 1,532 live births). Conceptions in spring resulted in signiﬁcantly more
children with birth defects than found in any other season (7.6 vs. 3.7%). Twelve families had
more than one child with a birth defect (n = 28 children). Forty-two percent of the children from
families with recurrent birth defects were conceived in spring, a signiﬁcantly higher rate than that
for any other season. Three families in the kinships defined contributed a first-degree relative
other than a sibling with the same or similar birth defect, consistent with a Mendelian inheritance
pattern. The remaining nine families did not follow a Mendelian inheritance pattern. The sex
ratio of children with birth defects born to applicator families shows a male predominance (1.75
to 1) across specific pesticide class use and exposure categories exclusive of fungicides. In the
fungicide exposure category, normal female births significantly exceed male births (1.25 to 1).
Similarly, the proportion of male to female children with birth defects is signiﬁcantly lower (0.57
to 1; p = 0.02). Adverse neurologic and neurobehavioral developmental effects clustered among
the children born to applicators of the fumigant phosphine (odds ratio [OR] = 2.48; conﬁdence
interval [CI],  1.2–5.1). Use of the herbicide glyphosate yielded an OR of 3.6 (CI, 1.3–9.6) in the
neurobehavioral category. Finally, these studies point out that a) herbicides applied in the spring
may be a factor in the birth defects observed and b) fungicides can be a signiﬁcant factor in the
determination of sex of the children of the families of the RRV. Thus, two distinct classes of pes-
ticides seem to have adverse effects on different reproductive outcomes. Biologically based conﬁr-
matory studies are needed. Key words: birth defects, pedigree, pesticides, season, sex ratio.
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the phone interview, applicators and/or their
partners were also invited to participate and
return a detailed written reproductive health
and pesticide use assessment questionnaire.
Informants for the reproductive study
were 228 male spouse only (pesticide appli-
cator), 90 female spouse only, and 377 cou-
ples. Thus, at least one member of 695
families responded and gave detailed infor-
mation regarding reproductive health and
pesticide use. Of the 695 families, self-
reports from 133 informant families indi-
cated that they did not have children. Of
this group, 54 stated they did not want to
have children, 15 stated difficulty having
children, and 64 gave no detailed statement
regarding child-bearing status. Each written
survey was sent separately to the applicators
and their partners. In toto, this stepped
approach to detailed reproductive health sur-
vey met University of Minnesota institu-
tional review board approval and concerns
regarding privacy and data reporting.
Eligibility Criteria
General. All self-reported live births fathered
by a pesticide applicator (n = 536) were con-
sidered in this study. Live births and chil-
dren with birth defects were defined by
written survey. Findings regarding preg-
nancy losses, including miscarriages, are dis-
cussed elsewhere (4). In the present effort,
birth defects occurring in a total of 1,532
live births were considered in these analyses.
Births and congenital anomalies. Each
study participant was provided with a writ-
ten consent form to allow us to follow-up
and confirm parent-reported reproductive
health information through birth certiﬁcate
and medical records examination. For sub-
jects with adult children (>18 years of age),
specific written consent by the adult child
was required for these conﬁrmatory studies.
Where specific permission was given by a
parent or adult child, follow-up on
anatomic (structural) anomalies was per-
formed. Pertinent medical records were
obtained from the cooperating clinic or
medical facility of record through the allied
health staff and/or medical records depart-
ment. Each clinical note and diagnosis was
reviewed by a physician and genetic research
associate. Our assessments also included
clinically diagnosed and/or laboratory
test–defined genetic and metabolic anom-
alies that have an anatomic component
(e.g., Marfan’s syndrome, gangliosidosis,
Poland’s syndrome, and Down’s syndrome).
All reported anomalies were recorded
according to the International Classification
of Disease, 9th Revision (5). Birth anomalies
were grouped according to major organ sys-
tem as previously described (3).
Confounding variables such as maternal
smoking, drinking, age, and chronic diseases
such as diabetes and hypertension were
examined. In this retrospective study, where
possible, familial genetic history (pedigree),
pregnancy medication use, and nonmedici-
nal drug use (including vitamins) were
assessed in families with birth defects.
Developmental neurobehavorial conditions
such as autism, attention deficit disorder
(ADD), and its variants were not considered
in our detailed follow-up studies because of
limited access to uniform diagnostic
neurobehavioral information.
Families Reporting Multiple
Children with Birth Anomalies
Detailed genetic and familial histories were
obtained through follow-up questionnaire
and brief interview of these study subject
families. Consanguinity, occurrence of birth
anomalies, and similar birth anomalies
among parents, their siblings, and the chil-
dren of their siblings were considered.
Where possible, a pedigree was constructed
detailing birth anomalies, cause of death,
and age at death of family members, includ-
ing grandparents and their siblings.
Pesticide Use
Each certified pesticide applicator was
initially interviewed by phone regarding
current and past pesticide use in agriculture
with specific attention to product name,
years used, and the number of days per year
applied. Approximately 6 months later,
where possible, the subject was reinter-
viewed by written questionnaire to docu-
ment common pesticide use by pesticide
class, acreage treated, type of crop, and use
of personal protective gear. Overlap between
the two questionnaires was intentional to
validate use of pesticides by class (herbi-
cides, insecticides, fumigants, fungicides).
Phone survey pesticide use information was
employed in our assessments in those
instances where follow-up written pesticide
use information was lacking. Similarly, the
spouse of the applicator was interviewed by
phone and again by written questionnaire.
Involvement in the processes associated with
pesticide use, both historically and cur-
rently, was assessed. Personal use of pesti-
cides by spouses was also ascertained. Where
possible, specific pesticide exposure and/or
use was identiﬁed.
Statistics
Where appropriate, regression analysis,
two-sided t-tests, and analysis of variance
methods were employed. Variables consid-
ered for regression analysis included
mother’s age, smoking status, alcohol use,
and season of conception. Chronic diseases
such as diabetes, pharmacologically treated
hypertension, and arthritis and occupations
other than agriculture were considered sep-
arately. Specific medication use during
pregnancy and dietary information were
not considered in our survey. Residence at a
rural site (towns with populations <3,000)
or on a farm during childhood (<18 years
of age) was considered a factor in some of
these statistical analyses.
Results
General
Seventy children born to 536 couples had
one or more birth defects (Table 1). Five
children had other developmental anomalies:
autism (n = 2) and diabetes (n = 3) diag-
nosed at age 3 or older. Detailed conﬁrma-
tory studies were performed through medical
records and birth certificate examination.
Medical records and/or birth certiﬁcate con-
firmation were obtained for 54 of 70 chil-
dren (77.1%) with birth defects. Other
parent-reported children with birth defects
where the male spouse was not the father
(n = 3) and/or was not an applicator (n = 3)
were excluded from analyses. Similarly, of 19
children with ADD/attention-deﬁcit hyper-
activity disorder (ADHD), 5 were excluded
from data analyses because the male applica-
tor spouse was reported as not being the
biologic father.
The mean age (±SD) of the parents at
the time of birth of each child (mother, 25.4
± 4.8 years; father, 28.5 ± 5.3) with a birth
defect and those families with children with-
out birth defects (mother, 26.4 ± 4.9 years;
father, 28.7 ± 5.3) were not signiﬁcantly dif-
ferent. The survey-reported frequencies of
smokers, ex-smokers, and nonsmokers are
not different among male or female parents
of children with or without birth defects.
The frequency of drinking alcoholic bever-
ages (weekly, monthly) among the parents of
children with and without birth defects was
no different. Birth years covered in this
study, by quartiles, range from 1968 to
1998, with the median frequency of all
births being in 1978.
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Table 1. Births, birth defects, and other develop-
mental abnormalities.a
Population Totals
Live birthsb 1,532
Family participants 695
Families with children 536
Congenital birth anomalies 70
Autism 2
Childhood diabetes 3
ADD/ADHD 14
aThe table lists all births and birth and developmental
anomalies reported by study subjects where the pesti-
cide applicator is the father. bIncludes twins and other
multiple births. Comparison of Birth Defect
Frequencies Identiﬁed in the First
Year of Life and Later
The frequency of birth defects during the
first year of life reported for this cross-
sectional study shows a 1.5-fold or more
increase in the frequency of most birth
defects compared with the birth certificate
data from our earlier cohort study (Table 2).
The overall frequency of birth defects in the
categories examined is signiﬁcantly higher in
the cross-sectional study compared with the
cohort study when all parent-reported birth
defects are considered (p = 0.005) but not
when only conﬁrmed cases are considered (p
= 0.10). Curiously, our birth record–
reported frequencies for 1989–1991 (3) for
urogenital birth defects are nearly identical
to those found in the present study covering
birth years from 1968 to 1998. These data
suggest that the rate of urogenital birth
defects is constant over time and that these
anatomic defects are, for the most part,
observable at birth. Conﬁrmation by birth or
death records from our cross-sectional study
accounted for only 60% of the total birth
defects confirmed through medical records
assessment of the ﬁrst year of life.
Fifty-eight of 76 birth defects recorded
(Table 3) were conﬁrmed by medical records
review (76.3%). In 15 cases (19.7%), access
to medical records was denied by an adult
child. The remaining birth defects (4%)
remained unconfirmed but were accounted
for either by hospital closure and/or with no
record found by the medical reporting facil-
ity. As indicated in Table 3, 70 children had
birth defects; 6 of these children had more
than one birth defect (7.0%) for a total of 76
birth defects. We elected to include all
parent-reported birth defects in our analyses
based on the data reported above.
Recurrent Birth Defects
Pedigree analysis. Twelve families had a total
of 45 children. Two or more children from
each of these families had a birth defect, for
a total of 28 children with one or more birth
anomalies (Table 4). Other than a child’s
sibling, only three families (No. 1, 4, 5) in
the kinships defined contributed a first-
degree relative with the same or similar birth
defect involving the same organ system, sug-
gesting a familial or Mendelian origin.
Siblings from 5 of the 12 families (No.
2, 6, 8, 11, 12) with recurrent birth defects
had the same or similar birth defect. These
findings are consistent with larger studies
that demonstrate that families with one
child with a birth defect are more likely to
have a second child with the same or similar
birth defect (6–8). These data infer familial
susceptibility. Two children from family
No. 6 had an annular pancreas consistent
with a dominant mutational event in the
current generation. Case reports support
this contention (9,10). Six families in the
kinships listed (No. 2, 3, 6, 8–10) gave no
prior family history of children with similar
or the same birth anomalies, suggesting a
nonfamilial etiology.
Four families in the group of 12 families
(No. 3, 7, 9, 10) had children with different
birth defects. Eight of nine children with
these birth defects were conceived in spring
or early summer (before 15 July). One child
with a musculoskeletal deformity (from fam-
ily No. 10) was conceived in fall. Previous
studies by other investigators (6–8) conclude
that families with children with one class of
birth defects have a low likelihood of having
a second child with a different class of birth
defect. Since the birth and developmental
anomalies within each of these four families
differ by organ system, these untoward
reproductive events suggest nonmutagenic
teratogenic effects.
To summarize, the analysis of the pedi-
gree data (Table 4) showed that 3 of the 12
families with more than one child with a
birth defect follow a Mendelian or familial
birth anomaly pattern. The remaining 9
families do not follow a familial pattern, at
least in the limited size of the kindreds
examined.
Preliminary statistical analysis. To
measure the likelihood of having more than
one child with a birth defect, the data were
analyzed conditional on the number of chil-
dren. For parents with a single child, the
birth defect rate was 8.4%. For families with
two children, the birth defect rate was 5.9%.
One of these families had birth defects in
both children, compared with an expected
number of 0.3. Thus, the family is probably
unusual. For families with three children,
the birth defect rate was 5.7%. Six of those
families had two or more children with birth
defects, compared with an expected number
of 1.5. Thus, four or ﬁve of the six families
with multiple birth defects are unusual,
whereas one or two are a chance occurrence.
In families with four children, the rate was
3.9%. Two of those families had two or
more children with birth defects, compared
with the expected number of 0.7. Thus, one
of the two families is likely unusual. In fami-
lies with five children, the rate was 6.0%.
Two of those families had three or more
children with birth defects, compared with
the expected number of 0.06. In families
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Table 2. Comparison of the frequency of self-reported (cross-sectional study) birth anomalies with birth
certiﬁcate–based cohort study.a
Number of cases (n) and rate (R) of birth defects  
per 1,000 live births recorded in the ﬁrst year of life
Cross-sectional study
nn Cohort study (1989–1992)
Organ system (self-reported) (conﬁrmed) Rb n R
Central nervous system 7c 7 4.6 6 1.3
Cardiovascular/respiratory 8 8 5.2 17 3.7
Musculoskeletal/integument 21 15 9.8 30 6.5
Gastrointestinal 3 3 2.0 6 1.3
Urogenital 6 6 4.0 20 4.4
Chromosome, genetic, metabolic  3 1 0.65 8 1.7
Totals 48 40 26.1 87 18.9
aIn these crude comparisons, the overall frequency of self-reported and medically conﬁrmed birth anomalies recorded in
the ﬁrst year of life is higher than those recorded in our earlier birth certiﬁcate–based cohort study (3). Regardless of
ascertainment method, urogenital birth defects were reported at about the same rate (4.0 vs. 4.4 per 1,000). bBirth defect
rate in cases conﬁrmed by medical records within the ﬁrst year of life. cIncludes anomalies of the eye and hearing.
Table 3. Birth defects, major organ system, parent report conﬁrmation, and age at diagnosis.a
Conﬁrmation Refusal
Age at reported diagnosis by medical  by adult 
Birth defect No. cases <1 years 1–3 years >3 years records child
Central nervous system 14 7 3 4 11 3
Cardiovascular system 13 8 0 5 10 3
Gastrointestinal system 4 3 0 1 4 0
Urogenital system 9 6 1 2 8 1
Musculoskeletal system  27 17 4 6 17 7
Skin/integument 4 4 0 0 4 0
Cytogenetic/metabolic 5 3 0 2 4 1
Totals 76b 48 8 20 58 15
aIdentified in the table are the number of parent-reported birth defects by organ system age at diagnosis and through
medical record confirmation. More than 75% of the reported birth defects were confirmed by medical records.
Approximately 80% of the adult children in the remaining 25% of cases reported refused permission for examination of
medical records. bFive children had more than one birth defect and more than one organ system was involved. One
twin birth yielded an additional case.with six or more children, the rate was 3.0%.
One of those families with two children with
birth defects cannot be considered unusual.
In sum, on the basis of this methodology,
there are probably 8 or 9 unusual families
among the 12 families with multiple children
with birth defects. These preliminary statisti-
cal ﬁndings are reported independently of the
pedigree analysis; each indicates that 9 of the
12 families studied are “unusual” or non-
Mendelian and may be at special risk.
Other known contributors to special risk
for recurrent birth defects are recurrent mis-
carriages and other fetal losses (11). On the
basis of parent-reported data, there were no
recurrent pregnancy losses (data not shown),
including miscarriages and other fetal losses
in the families with recurrent birth defects.
Pesticide Use, Children with Birth
Defects, and Adverse Developmental
Effects
Table 5 compares the relative frequency of
use (%) of commonly applied pesticides
reported from phone survey and in the sub-
sequent, more detailed, self-reported writ-
ten survey performed at least 6 months
later. The overall results obtained from the
different survey methods and instruments
employed are nearly identical. These data
demonstrate little difference in recall
among study subjects regarding specific
pesticide class use. Further, the frequency
distribution of products used by applicators
participating in the reproductive study was
no different from that of the products
applied by the general study population.
Based on application practice, applicator
exposure can be assessed according to spe-
cific pesticide class use groups (herbicide
only; herbicide and insecticide; herbicide,
insecticide, fungicide; herbicide, insecticide,
fumigant; and use of all four classes of pes-
ticides), with use of herbicides only being
the referent group (12,13). The mean num-
ber of children per applicator per pesticide
exposure group varied from 2.5 (other) to
3.0 (herbicide only) children, with a mean
of 2.85 children per applicator for the
entire study group. There were no signifi-
cant differences in birth rate among
exposure groups.
Examination of the frequency of
applicator families with birth defects by pes-
ticide use class category (Table 6) shows
that 15.4% of applicators who applied
fumigants, insecticides, and herbicides had
at least one child with a birth defect com-
pared with 6.8% in the referent exposure
group who applied only herbicides. To min-
imize possible bias introduced by differences
in the reproductive rate per family
(Table 4), odds ratio (OR) comparison of
the number of applicators by pesticide use
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Table 5. Rank order comparison of reported use of pesticides by applicator participants from phone and
written survey.a
No. phone No. written
respondents Percent use survey respondents Percent
Class of pesticide (n = 1,071) reported (n = 596) use reported
Herbicides
Chlorophenoxy 786 73.4 385 64.6
Oxyphenoxy 380 35.5 176 29.5
Sulfonylurea 330 30.8 174 29.2
Carbanilate 303 28.3 133 22.3
Bromophenol 293 27.4 114 19.1
Benzothiazole 233 21.8 105 17.6
Nitroaniline 209 19.5 92 15.4
Insecticides
Organophosphate 478 44.6 252 42.3
Synthetic pyrethroids 201 18.8 116 19.5
Carbamate 128 12.0 42 7.1
Fungicides
Organotin 216 20.2 117 19.6
Ethylene bisdithiocarbamate 154 14.4 77 12.9
Triazole 129 12.0 61 10.2
Fumigants
Phosphide 138 12.9 101 17.0
Other 4 0.3 5 0.8
aListed in the table by chemical class are commonly used pesticides, including herbicides, that were applied by applica-
tors. Five hundred ninety-six men who responded to the phone survey (n = 1,071) detailing general health and pesticide
use, and who were married or had a marriagelike relationship (n = 851) participated in the written survey 6 months later
detailing reproductive health and pesticide use. Comparison of the data by rank order use demonstrates that pesticide
use by the applicators participating in the reproductive study was not signiﬁcantly different from that of the more general
RRV population participants.
Table 4. Families with more than one child with a birth defect.a
Family pattern Multiple birth defects
Subject No. of children Total no. 1st degree 2nd degree
family with BD of children BD category Same/similar BD Other BD Same/similar BD Other BD
12 7 Cardiovascular Yes Yes Yes No
23 3 Musculoskeletal No No No No
32 3 Nervous system No No No No
Musculoskeletal
42 3 Musculoskeletal Yes No Yes No
52 2 Musculoskeletal Yes Yes No No
62 4 Gastrointestinal No No No No
73 4 Skin/integumental, No No Yes Yes
urogenital
82 3 Musculoskeletal No Yes No No
92 3 Musculoskeletal, No No No Yes
nervous system
10 3 5 Musculoskeletal, No Yes No No
nervous system
11 2 3 Musculoskeletal No No Yes Yes
12 3 5 Nervous system No No Yes Yes
Totals 28 45 3/12 4/12 5/12 4/12
BD, birth defects. aReported in the table are the number of families with more than one child with a birth defect. Birth defects by major organ system, number of children with a birth
defect, and the total number of children in the family are identiﬁed. First-degree relatives of the parent informant or spouse of the informant are listed in separate columns. In this sce-
nario ﬁrst-degree relatives include mother, father, brother, or sister of the informant or spouse. Children of the informant family are excluded. Second-degree relatives of parent infor-
mants (grandparents, uncles and aunts and children of siblings) are listed under a separate column. Twelve families had 28 children with a birth defect. Sixty-two percent of the total
number of children born to these families (n = 45) had a birth defect.group with and without children with birth
defects was performed (Table 6). For exam-
ple, 6 of 39 applicators who applied fumi-
gants had a child with a birth defect,
compared with 8 of 118 who applied herbi-
cides only, which gave an OR = 2.27 (95%
confidence interval [CI], 0.85–6.08).
Comparison of birth defects to total births
gave an OR of 2.0 (95% CI, 0.85–4.62) for
paternal application of fumigants, insecti-
cides, and herbicides compared with the ref-
erent group, which was not much different,
indicating that the number of children per
family was not a major factor in these
results. Since phosphine-generating phos-
phides (Table 5) were the only fumigants in
common use, and exposure group compar-
isons were suggestive, we examined in
greater detail the adverse birth and develop-
mental health effects in children born to
applicators who use these phosphine-gener-
ating products. Results recorded from these
more detailed efforts showed that 4 of 14
children whose father applied phosphine
had birth defects involving the central ner-
vous system. Two of 2 children with autism
and 5 of 14 who had parent-reported
ADD/ADHD had a biologic father who
applied phosphine. Curiously, 2 of the 4
children with a central nervous system birth
defect had a unilateral congenital cataract
involving the right eye and no other accom-
panying birth defect. These children, unex-
pectedly, were female. Altogether, 3.8% of
children whose parent used phosphine ver-
sus 1.5% of those who did not use the fumi-
gant had adverse central nervous system or
neurobehavioral sequelae (OR = 2.5; CI,
1.22–5.05). Similarly, use of the phospho-
namino herbicides (glyphosate, Roundup)
was overrepresented in the adverse birth and
developmental effect group. Forty-three per-
cent of the children (6 of 14) who had
parent-reported ADD/ADHD used phos-
phonamino herbicides (OR = 3.6; CI,
1.35–9.65). No other commonly used pesti-
cide compared by major organ and/or func-
tional system was uniquely associated with
specific adverse birth or developmental
effects. Use of different classes of pesticides
over the 4–6 months of agricultural pesticide
use compared with the use of herbicides and
no other pesticide class (herbicide use period,
~15 April to 1 July) suggests that interaction
among pesticide classes used may be a factor
in the birth defects observed (Table 6).
Sex of Children, Birth Defects, and
Fungicide Use
Table 7 reports and compares the frequen-
cies of birth defects among live-born male
and female children according to paternal
fungicide use. More male children are born
to families whose male partner did not apply
fungicides than to those who do apply these
products (p = 0.04). Regarding birth defects,
as expected, more male children are born
with birth defects than are female children
(M/F sex ratio = 1.8) when no fungicides are
applied. If fungicides are applied by the male
partner, far fewer male children with birth
defects are born (M/F sex ratio = 0.57, p =
0.02). The birth rate among families of
fungicide applicators with children is no dif-
ferent from those who apply herbicides and
other products (2.85 vs. 2.80 children per
family), suggesting that fertility is not a fac-
tor in these results.
Season of Conception
Conceptions in the fall led to the highest
number of births but not birth defects
(Table 8). Notably, conceptions in the spring
led to a significantly increased number of
birth defects (p = 0.02). Prematurity was not
a factor in these results (4). Coincidentally,
herbicides are routinely applied during the
same time frame (spring). Chlorophenoxy
herbicides were by far the most commonly
used herbicide group (Table 5).
Discussion
General
About 3.7% of children born on an average
day in the United States are said to have a
birth defect (14). Fifty-four of 536 pesticide
applicators who had children and partici-
pated in our study had at least one child
with a birth defect (10.1%; Table 6). Other
than these crude comparisons, enumeration
and determination of the frequency of fami-
lies with at least one child with a birth defect
has received little attention in the current
available literature. The frequency of birth
defects (structural, chromosomal, genetic,
and metabolic disorders) in relation to the
number of live births (76/1,532 or 5.0%
[Table 1, all cases] and 58/1,532 or 3.8%
[Tables 2 and 3, cases conﬁrmed by medical
Endocrine Disruptors • Birth defects and sex ratio
Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 3 | JUNE 2002 445
Table 7. Sex and sex ratio of children born to fungicide applicator families: with and without birth defects.
Births Male Female Sex ratio Chi-square
All children from families: 
Where fungicides were applied 373 408 0.91
p = 0.04
Where no fungicides were applied 387 343 1.13
Children with birth defects:
From families where fungicides were applied 13 23 0.57
p = 0.02
From families where no fungicides were applied 22 12 1.80
The sex ratios (SR) of live-born children with and without birth defects were compared according to paternal (pesticide
applicator) use of fungicides. Signiﬁcantly fewer male children with (SR = 0.65) birth anomalies (p = 0.02) and without (SR
= 0.91) birth anomalies (p = 0.02) were born to families where the father applied fungicides (chi-square).
Table 8. Birth defects by season of conception.a
Season of conception Total births Births with congenital anomaly Percent with anomaly
Fall 390 13 3.3
Winter 349 13 3.7
Spring 381 29 7.6*
Summer 377 15 4.0
Totals 1,497b 70 4.7
aThe number of births and birth anomalies resulting from conceptions in each season were examined. Compared  with all
other seasons, conceptions in the spring led to significantly more children with birth defects. bTotal number of self-
reported births recorded giving speciﬁc date of birth. *Chi-square, p = 0.002. 
Table 6. Children with parent-reported birth defects and paternal pesticide use.a
Total no. applicators No. applicators with children
with children who have birth defects
Exposure category n % n %O R95% CI
Herb/insect/fume 39 7.28 6 15.38 2.27 0.85–6.08
Herb/insect/fung 182 33.96 21 11.54 1.70 0.79–3.66
Herb/insect 73 13.62 9 12.33 1.82 0.74–4.46
Otherb 58 10.82 5 8.62 1.27 0.43–3.73
All four 66 12.31 5 7.58 1.12 0.38–3.29
Herb only 118 22.01 8 6.78 Referent
Abbreviations: fume, fumigants; fung, fungicide; herb, herbicide; insect, insecticide. aPesticide applicator exposure
groups were deﬁned by pesticide class use. In these comparisons, applicators who used herbicides but not other prod-
ucts were assigned to the referent group. The number of applicators who have children with and without birth defects
are reported in the table according to exposure group. Approximately 15% of applicators who apply herbicides, insecti-
cides, and fumigants have children with birth anomalies. More detailed analysis (see text) of specific fumigant use
shows that applications of the fumigant phosphine were associated with a signiﬁcant increase in adverse birth, develop-
mental, and neurobehavioral sequelae (OR = 2.5; CI 1.22–5.05). bAny pesticide combination not listed.  records]) is somewhat higher than that
reported from regional/national norms
[2.68% in Iowa (15)] and the U.S.
Department of Defense birth defect surveil-
lance system (3.2%) (16). Both of these
birth defect surveillance systems employ
active retrieval to ascertain cases and require
birth/death or medical record confirmation
for inclusion into the registry. The differ-
ences in the overall frequency of birth
defects we observed could reﬂect parent bias
in reporting, medical underreporting, and
notably in our study, the reticence of adult
children (Tables 2 and 3) to allow investiga-
tion of their birth and developmental med-
ical records. Anecdotal parent reports
suggested that the adult child had concerns
regarding privacy and/or health insurability.
Comparison (Table 2) of the data from
our earlier birth record cohort study (3) with
data from our current medical records-based
cross-sectional study shows a relatively uni-
form increase in the overall reported rate of
birth defects in the cross-sectional study.
These data also offer a tentative suggestion
that the relative rate of urogenital birth
defects in the RRV may be constant through
time.
Season of Conception and Birth
Defects
From our earlier-reported cohort study of
birth defects (3) in pesticide applicators
throughout Minnesota, we uncovered a sea-
sonal increase in the frequency of birth
defects occurring only in the RRV region of
our state. As stated and detailed in our ear-
lier publication, the valley is a unique wheat,
sugar beet, and potato crop-growing region
with specific pesticide use requirements.
Conceptions in spring, the time frame of
herbicide applications, led to an increased
frequency of birth defects. Our present
cross-sectional study reconﬁrms these initial
findings (Table 8). Interestingly, in our
report discussing fetal losses in this study
group (4), the frequency of first trimester
miscarriages also peaks in spring. The repeti-
tion of the spring season’s ﬁndings regarding
birth defects and the concordance with the
peak frequency of miscarriages are suggestive
of an environmental nonmutagenic origin of
these adverse reproductive effects. In reports
by others, the lack of a consistent seasonal
trend for birth defects overall (17,18) and
for particular birth defects (19,20) strength-
ens the possible connection with a seasonal
environmental exposure to herbicides or
other environmental contaminants uniquely
present in the RRV during spring but not in
other seasons. For example, shifts in the
trace contaminant levels in residential well
water during the spring thaw could be a
factor in our results.
Recurrence of Birth Defects
Recurrence of birth defects within our popu-
lation suggests that a segment of our study
group is at special risk (Table 4). Several
studies demonstrate that persons with one
child with a specific birth defect are much
more likely to have a second child with the
same or similar birth defect [Mueller and
Schwartz (6), relative risk (RR) = 11.7; Lie
et al. (7), RR = 7.6]. The reported relative
risk for having a second child with a differ-
ent birth defect was slightly increased [Lie et
al. (7), RR = 1.5; Mueller and Schwartz (6),
RR = 1.5]. Also reported in these two earlier
studies, the relative risks of having a second
child with any birth defect were, respec-
tively, 2.4 and 1.9. Further, in the study by
Basso et al. (8), 5.5% of women whose child
had a birth defect gave birth to a second
child with a birth defect sired by the same
father. In our study, 12 families contributed
28 children with birth defects. Twelve of 54
families (22.2%) where the father was a pes-
ticide applicator had more than one child
with a birth defect. Part of the differences in
frequency of recurrent birth defects between
the present study and the earlier studies by
other investigators (e.g., 5.5 vs. 22.2%) can
be due to differences in study requirements.
Alternatively, environmental factors might
give greater expression to birth defect suscep-
tibility. Larger-scale studies of families with
recurrent birth defects are needed to define
possible gene–environment interactions.
Sex and Sex Ratio of Children Born
to Applicator Families
The reported sex and M/F sex ratio (Table
7) of children with no reported birth defects
born to spouses of pesticides applicators
(M/F sex ratio = 1.01) show a reduction in
male births in the RRV compared with data
from our earlier study of the general popula-
tion of Minnesota (M/F sex ratio = 1.05).
Davis et al. (21) reported a long-term sus-
tained reduction in the ratio of male to
female births (1.06) in several industrial
countries (Denmark, Netherlands, Canada,
and the United States). It is generally
accepted that more male children are born
with birth defects (22). Among children
with birth defects, if fungicide use is consid-
ered, then the sex ratio of children with
birth defects born to applicators is much
reduced (M/F sex ratio = 0.57), whereas if
the male parent (applicator) did not use
fungicides, then the M/F sex ratio is 1.83 (p
= 0.02). This striking male predominance in
the occurrence of birth defects among appli-
cators who did not use fungicides is similar
to that in our earlier published work (5). In
this earlier ecologic study, fungicide use
could not be distinguished from chlorophe-
noxy herbicide use due to lack of data on
individual subject use of these products. In
the present, smaller-scale but more detailed
study, fungicide use by the male pesticide
applicator parent was associated with fewer
male births, most significant among chil-
dren with birth defects. Similarly, the
spouse of the pesticide applicator who
applied or used fungicides on the farmstead
is at a significantly higher risk for a first
trimester miscarriage (4). The majority of
these fungicide applications cited were
conducted by air.
The decline in the ratio of the number of
male to female children born to families
with paternal exposure to fungicides poses a
number of mechanistic questions. First, it is
well known (subject to some controversy),
that men in some environmental or occupa-
tional settings who were exposed to dioxins,
dibromochloropropane (a fumigant), or
boron, father significantly fewer live-born
male children (21,23–26).
Most recently, Sakamoto et al. (27)
reported a reduction of M/F sex ratio in
Minamata Bay fishermen and among
patients with Minamata disease, a disease
entity associated with signiﬁcant exposure to
the pollutant methylmercury. These data,
coupled with an increase in the number of
male stillbirths in the study population, led
the authors to speculate that the male fetus
may be more susceptible to pollutants/toxi-
cants. James (23) and others (21,24–26)
hypothesized that differences in sex ratio are
in part due to differences in the testos-
terone/gonadotropin ratio and blood levels
of these sex hormones in both parents at the
time of conception.
Indeed, under certain chronic disease
conditions, lower testosterone levels in males
have been associated with increased numbers
of female infants born to their spouse (28).
Astolfi et al. (29) noted that differences in
paternal human leukocyte antigen (HLA)
genotype were associated with differences in
testosterone levels. Lower testosterone levels
seen together with certain paternal HLA
phenotypes were associated with a high
number of daughters. These aforementioned
data imply that testosterone levels may be
relatively stable during much of male repro-
ductive life and may affect the sex of the
child. Regarding the role of the female in
determination of the sex of children,
Jongbloet et al. (30) suggested that several
hormonally related factors, including differ-
ences in the length of the follicular phase of
the menstrual cycle and the degree of matu-
ration of the oocyte, may lead to differential
attrition of the male conceptus.
Aside from the putative hormonal
connection to germ-cell maturation and sex
determination of the offspring, and of equal
concern, is the well-known role of X-linked
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the sex of viable offspring. The U.S.
Environmental Protection Agency (U.S.
EPA) has offered guidelines for the inclusion
of sex-linked recessive lethal screening test in
Drosophila as a means of identifying germ-
line mutations due to pesticides and other
products (31). The U.S. EPA estimates that
some 800 gene loci on the X chromosome
will yield a lethal mutation such that fewer
male offspring (F2 generation) result from
initial toxicant treatment of the male
Drosophila. The extent and general applica-
bility of these reproductive toxicant studies
in Drosophila to humans have not, to our
knowledge, been examined in detail.
In humans, skewed frequency of X chro-
mosome inactivation in female carriers of
proposed X-linked lethal genes has been
associated with recurrent spontaneous abor-
tions (32). In modeling these data, Lanasa
et al. (33) suggested that the female carrier
undergoes selective inactivation of the nor-
mal X chromosome; the remaining abnor-
mal active X chromosome in a conceptus
would be aborted. Confirmatory studies by
these investigators are consistent with the
initial hypothesis (34). Fewer boy children
were born to female carriers. On the other
hand, rare X-linked mutations (carriers of
X-linked juvenile retinoschisis [RS]) have
been associated with increased number of
male offspring (35). These investigators
showed that RS1 gene expression was con-
ﬁned to the uterus and speculated that RS1
protein has a role in implantation.
To summarize, it appears that determi-
nation of the phenotypic sex of children in
human populations can be altered by
X-linked mutational effects in a maternal
carrier. Similarly, alteration of the sex-
determining region (SRY) of the Y chromo-
some affects mammalian sexual development
(36). Altogether, events associated with sex
chromosome mutation are known determi-
nants of the sex of offspring (22).
Finally, whether fungicides play a
hormonal role, exert a mutational effect, or
are aneugenic in the determination of sex of
offspring is uncertain. Triphenyl tin (TPT)
and mancozeb, fungicides in use for the past
20 years or more and that are in common
use in the RRV, induce apoptosis in vitro.
TPT alone induced aneuploidy (37,38).
TPT is also an inhibitor of aromatase (39), a
P450 enzyme that catalyzes the conversion
of testosterone to estrogen in males. With
respect to mutagenesis, as stated above, there
is little information to suggest that TPT is a
signiﬁcant mutagen (40).
Mancozeb, a member of the ethylene
bisdithiocarbamate fungicide group, is weakly
mutagenic but is a signiﬁcant thyroid carcino-
gen in animals (41,42) and affects thyroid
function in humans (43). Studies at the germ
cell level, including the recessive lethal test in
Drosophila, were negative (44,45).
Birth Defects
Division of the pesticide-exposed population
according to pesticide use by class (Table 6)
and examination of the frequency of birth
defects, revealed an interesting but non-
significant excess of birth defects among
applicators who apply fumigants and other
products (OR = 2.27; CI, 0.85–6.08).
Inclusion of neurodevelopmental abnormali-
ties led to a statistically significant result
(OR = 2.5; CI, 1.2–5.1). As mentioned in
“Results,” phosphine derived from the phos-
phide was the major fumigant in use. This
highly toxic, denser-than-air gaseous fumi-
gant can be genotoxic (46). DNA damage
expressed as increased DNA adducts (47) or
excess chromosome breakage and rearrange-
ment has been noted (48). In this connec-
tion, we recorded two cases of congenital
cataracts from different families among 290
children born to 113 applicators who apply
this fumigant. No antecedent family history
of cataracts was noted in either family, nor
was there history of pregnancy-associated
diabetes or rubella (49). In the United States
(Birth Defects Monitoring Program), the
reported frequency of congenital cataracts is
between approximately 1.1–2.2 per 10,000
live births (50). Speciﬁc studies of congenital
ocular anomalies in the United Kingdom
(51) put the frequency of this class of con-
genital defect up to 3.5 per 10,000 live
births through age 15. It appears that chemi-
cal induction of this birth defect either
through dominant or recessive mutation
(52–54) or by direct chemical toxicity to the
developing fetus (55) is a distinct possibility
and concern. Based on the laterality pattern
observed (right eye only) in both cases,
germ-cell mutation seems more likely (56).
In relation to occupation, paternal exposure
to dioxin-contaminated chlorophenols in the
sawmill setting has been associated with
excess congenital cataracts in children born
to these workers (57). Connection with the
present study is tentative. Other laboratory-
based studies examining possible dioxin con-
tent of chlorinated pesticides in current use
are under way.
Again, we noted that the two cases of
parent-reported autism clustered within the
phosphine-use group. Current data (58) esti-
mates the prevalence of autism somewhere
between 1 and 2 per 1,000 in children less
than 15 years of age, similar to the frequency
reported in our entire study group (2
cases/1,532 live-born children) but highly
prevalent in the paternal phosphine-use
group (2 cases/290 live births). Genes
involved in susceptibility to autism have been
mapped to chromosome locus 7q32.3-q33
(59,60). The Online Mendelian Inheritance
in Man (61) places a putative autism suscep-
tibility region at 7q31. Giemsa-banded chro-
mosome studies of phosphine-exposed
workers performed by our group showed that
breakage at these chromosome loci (7q31
and/or 7q32) was more common among
phosphine-exposed workers than among
control subjects (12,48,62).
Regarding phosphine, 5 of 14 parent-
reported ADD/ADHD cases were recorded
in this exposure group. Current reports of
the prevalence of ADD/ADHD show much
variability. A study of children from
Manitoba, Canada (63), showed a preva-
lence rate of 1.5%. The combined preva-
lence of ADD/ADHD reported by Nolan et
al. (64) in the United States was 3.5%; and
Brown et al. (65) reported that the frequency
varied from 4 to 12% of children. In the
present study (Table 1), parents reported 14
cases among 1,532 live births, less than
expected. However, the prevalence of
ADD/ADHD among children of phosphine
applicators (5 of 290, or 1.7%) is about the
same as that in the Canadian studies.
Altogether, these neurologic, neurodevel-
opmental, and neurobehavioral data suggest
that phosphine may affect the developing
nervous system, perhaps at critical times (66)
or by germ-cell mutation.
Regarding the herbicide glyphosate, our
present study shows a tentative association
between ADD/ADHD and use of this herbi-
cide. In vitro studies by our group show that
this product was not genotoxic in the
micronucleus assay (67) and did not have
significant pseudoestrogenic effects in
MCF-7 cells (37). In a recent review of the
toxicology of glyphosphate (68), little if any
evidence of neurotoxicity was noted other
than by intentional ingestion (69).
Finally, of the 14 pesticides identiﬁed by
class (Table 5), only phosphine and glyphos-
phate showed a significant correlation with
excess adverse birth and neurodevelopmental
effects. Whether these observations were
chance associations remains a concern.
Further detailed neurodevelopmental studies
are required to resolve these issues.
Summary
Previously, we showed that applicators and the
general population of the RRV had the high-
est birth defect rate in the state of Minnesota
(3). In the present more detailed study, we
showed that in families of fungicide applica-
tors from the RRV, the number of live-born
male children with or without birth defects
was significantly reduced. As in our earlier
study, conceptions in the spring led to signiﬁ-
cantly more children with birth defects com-
pared with children conceived in any other
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agents present in the spring, perhaps herbi-
cides, have an adverse effect on the birth defect
rate. A different class of agent, probably fungi-
cides, selectively affects the survival of the male
fetus. Aneuploid events and endocrine disrup-
tion alone or in combination are plausible bio-
logic mechanisms for the adverse reproductive
effects observed. Biologically based human,
animal, and in vitro studies are needed to test
these hypotheses.
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